vertex decene DOT

amprenavir | 1-decene | sodium bromate

| amprenavir | 1-decene | sodium bromate formula | C_25H_35N_3O_6S | CH_3(CH_2)_7CH=CH_2 | NaBrO_3 Hill formula | C_25H_35N_3O_6S_1 | C_10H_20 | BrNaO_3 name | amprenavir | 1-decene | sodium bromate IUPAC name | [(3S)-oxolan-3-yl] N-[(2S, 3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate | dec-1-ene | sodium bromate alternate names | (none) | alpha-decene | dec-1-ene | decylene | N-1-decene | N-decylene | DOT | dyetone mass fractions | C (carbon) 59.4% | H (hydrogen) 6.98% | N (nitrogen) 8.31% | O (oxygen) 19% | S (sulfur) 6.34% | C (carbon) 85.6% | H (hydrogen) 14.4% | Br (bromine) 53% | Na (sodium) 15.2% | O (oxygen) 31.8%

Structure diagrams

3D structure

| amprenavir | 1-decene | sodium bromate molar mass | 505.6 g/mol | 140.27 g/mol | 150.89 g/mol phase | solid (at STP) | liquid (at STP) | solid (at STP) melting point | | -66.15 °C | 381 °C boiling point | | 170 °C | 1390 °C density | | 0.741 g/cm^3 | 3.339 g/cm^3 solubility in water | | | soluble

| amprenavir predicted LogP hydrophobicity | 1.85 predicted LogS | -4.01

amprenavir | acenocoumarol | alprazolam | aluminum | amiodarone | anisindione | astemizole | atorvastatin | bepridil | bismuth subsalicylate | calcium | cisapride | clorazepate | cyclosporin A | delavirdine | diazepam | dicumarol | dihydroergotamine | dihydroxyaluminium | disulfiram | ergotamine tartrate | ... (total: 43)